Home Home Home Inbox Home Search

Event

PBI-4050, a Novel First-in-Class Antifibrotic Agent, Improves Pulmonary Hypertension and Fibrosis, as Well as Right Ventricular Hypertrophy and Fibrosis in Monocrotaline-Treated Rats [Board No. 1020]

Location: Board no. 1020
Session Type: Poster Discussion Session
Monday
May
21
2:15 PM
4:15 PM

Speaker(s)/Author(s)

Jean Claude. Tardif

MD, Ph.D.
Institut de Cardiologie de Montreal

Pierre Laurin

M.Sc.
Prometic Biosciences Inc.

Jocelyn Dupuis

MD, PhD
Institut de Cardiologie de Montreal

Lyne Gagnon

Ph.D.
Prometic Biosciences Inc.

Emily Nguyen-Duong

Ph.D.
Institut de Cardiologie de Montreal

Quang Trinh Nguyen

Ph.D.
Institut de Cardiologie de Montreal

Yanfen Shi

Ph.D.
Institut de Cardiologie de Montreal

Brigitte Grouix

Ph.D.
Prometic Biosciences Inc.

Elisabeth Plante

Ph.D.
Institut de Cardiologie de Montreal

View Abstract

PBI-4050, a Novel First-in-Class Antifibrotic Agent, Improves Pulmonary Hypertension and Fibrosis, as Well as Right Ventricular Hypertrophy and Fibrosis in Monocrotaline-Treated Rats

Parent Sessions

  • B108 - PULMONARY HYPERTENSION: THE LATEST FINDINGS...
    05-21-2018 2:15 PM - 4:15 PM
    • Home Home Home Inbox Home Search